[REGN] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 15.36%
YoY- 42.21%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 1,711,800 1,927,800 1,663,496 1,608,022 1,511,485 1,582,447 1,500,673 9.18%
PBT 546,100 676,200 635,861 656,074 585,398 554,767 565,605 -2.31%
Tax 85,000 -144,200 41,206 104,662 107,418 381,248 177,288 -38.76%
NP 461,100 820,400 594,655 551,412 477,980 173,519 388,317 12.14%
Tax Rate -15.56% 21.33% -6.48% -15.95% -18.35% -68.72% -31.34% -
Total Cost 1,250,700 1,107,400 1,068,841 1,056,610 1,033,505 1,408,928 1,112,356 8.13%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 26.94 42.56 35.75 34.29 31.62 10.97 25.88 2.71%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS 4.23 7.58 5.51 5.12 4.44 1.62 3.64 10.54%
EPS Diluted 3.99 7.15 5.17 4.82 4.16 1.49 3.32 13.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.